v3.26.1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Profit or loss [abstract]      
Revenues $ 856 $ 1,306 $ 2,879
Cost of revenues 225 800 683
Gross profit 631 506 2,196
Research and development expenses 2,097 1,707 1,641
Sales and marketing 912 1,515 2,484
Impairment of intangible assets 115 1,344 1,042
General and administrative expenses 6,371 4,526 3,844
Other income, net (490) (1,270)
Operating loss 8,374 7,316 6,815
Equity losses of an associate 500 429 210
Gain from sale of an associate (2,231)
Finance income (2,278) (612) (2,219)
Finance expenses 8,199 353 1,055
Loss before income taxes 12,564 7,486 5,861
Taxes on income (14) 22
Net loss and total comprehensive loss 12,564 7,472 5,883
Attributable to:      
Equity holders of the Company 12,179 6,284 5,122
Non-controlling interests 385 1,188 761
Profit loss $ 12,564 $ 7,472 $ 5,883
Basic loss per ordinary share attributable to equity holders of the Company (in Dollars per share) [1] $ 98.07 $ 203.89 $ 2,374.55
Diluted loss per ordinary share attributable to equity holders of the Company (in Dollars per share) (in Dollars per share) [1] $ 98.07 $ 203.89 $ 2,374.55
[1] Share and per share data in these consolidated financial statements have been retrospectively adjusted, for all periods presented, to reflect a number of shares that is equivalent to the number of shares of the Company post the Fifth Reverse Share Split (see note 18a).